Recent Press Releases

Bristol-Myers Squibb and QIMR Berghofer Medical Research Institute Announce Worldwide Collaboration to Discover Novel Immuno-Oncology Antibodies

NEW YORK & QUEENSLAND, Australia--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and QIMR Berghofer Medical Research Institute have signed a research collaboration and license...

Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant

WOODCLIFF LAKE, N.J. and STAMFORD, Conn., Aug. 31, 2015 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., and Purdue Pharma L.P. announced today that they have...

Neurovive Pharmaceutical: NeuroVive refocuses CicloMulsion development – discontinues acute myocardial infarction indication

STOCKHOLM--Regulatory News: CicloMulsion® development to continue in acute kidney injury and increased focus on development of other drug candidates. Shareholder information meeting to be held...

FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis

NEW YORK, Aug. 31, 2015 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of...

Google's life sciences team's first major area of focus: diabetes

August 31, 2015 People living with diabetes have to keep their blood sugar levels in a normal range using a combination of diet, exercise, and medication. Yet even today, this involves a surprising...

Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases

Bristol-Myers Squibb Company (BMY) and Promedior, Inc. announced the companies have entered into an agreement that grants Bristol-Myers Squibb an exclusive right to acquire Promedior and gain...

Bayer Expands Finerenone Clinical Development Programme with Three Phase III Studies in Patients with Chronic Heart Failure and Patients with Diabetic Kidney Disease

Decision based on data of four dose-finding studies in patients with chronic heart failure and diabetic kidney disease Berlin, August 31, 2015 – Bayer HealthCare announced today the...

Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases

Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases August 31, 2015 08:30 AM Eastern Daylight Time...

Celgene Completes Acquisition of Receptos, Advancing Leadership in Immune-Inflammatory Diseases

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced it has closed its acquisition of Receptos, Inc. Receptos stockholders received $232.00 per share in cash, for a total...

Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX As Chief Medical Officer

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2015 /PRNewswire/ -- CytomX Therapeutics, Inc., a biopharmaceutical company developing Probody therapeutics for the treatment of cancer, today announced that...

Halo Pharmaceutical, Inc. Makes Key Additions To Management Team

WHIPPANY, N.J., Aug. 26, 2015 /PRNewswire/ -- Halo Pharmaceutical, a rapidly growing Contract Development and Manufacturing Organization (CDMO), is pleased to announce the appointments of Lee Karras...

Adare Pharma Appoints Joseph Del Buono As Vice President, Finance And Chief Financial Officer

PRINCETON, New Jersey, August 26, 2015 - Adare Pharmaceuticals, Inc., formerly Aptalis Pharmaceutical Technologies, announced today that Joseph (Joe) Del Buono has joined the Company as Vice...

Velano Vascular Appoints Former Cardinal Health (CAH) Vice Chairman David Schlotterbeck To Board Of Directors

SAN FRANCISCO and PHILADELPHIA, Aug. 26, 2015 /PRNewswire/ -- Velano Vascular, a medical technology company transforming and enhancing the care experience for hospitalized patients and their...

Human Longevity Inc. Hires Life Sciences Leader, Mark Winham, As Chief Operating Officer

SAN DIEGO, Aug. 25, 2015 /PRNewswire/ -- Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that Mark A. Winham has joined the company as Chief Operating...

INC Research (INCR) Enhances Therapeutic Expertise With Key Promotions In General Medicine And CNS

RALEIGH, N.C., Aug. 25, 2015 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced the promotions of Bekki...

AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace To Advisory Board

NEW YORK, Aug. 26, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce the latest appointment to its Board of Advisors: Mr. Joe Grace. A proven business and marketing...

Amneal Announces New Biosciences Unit With Charles Lucarelli As President

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal today announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC (www.amneal.com). Amneal Biosciences will focus...

PAREXEL International (PRXL) Names Maykin Ho To Board Of Directors

BOSTON, Aug. 26, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that its Board of Directors have elected...

Epic Sciences Appoints Dave Henderson As Chief Information Officer

SAN DIEGO, Aug. 26, 2015 /PRNewswire/ -- Epic Sciences, Inc. ("Epic Sciences"), announced today the appointment of Dave Henderson as Epic Sciences' chief information officer (CIO). Mr. Henderson has...

Xagenic Appoints Seasoned Industry Veteran Randall Wilhoite As Vice President Of Operations

TORONTO--(BUSINESS WIRE)--Xagenic, a molecular diagnostics company developing the Xagenic X1™ platform for use at the point of care, today announced that Randall Wilhoite has joined the Company...